EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy

Angela Casado-Adam, Robert Alderman, O Anthony Stuart, David Chang, Paul H Sugarbaker

International Journal of Surgical Oncology · 2011

DOI: 10.1155/2011/468698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Surgical Oncology, 2011. Verfasst von Angela Casado-Adam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Washington Cancer Institute, Washington Hospital Center, Washington, DC 20010, USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is increasingly used in the treatment of peritoneal carcinomatosis from gastrointestinal malignancies. The purpose of this study is to reevaluate the incidence of gastrointestinal events and identify risk factors associated with this treatment approach. Between January 1, 2006 and December 31, 2009, 147 patients with appendiceal and colorectal carcinomatosis were treated. Gastrointestinal events were analyzed. The overall incidence of grade I–IV gastrointestinal events was 17%. There were 4 grade III gastrointestinal events that occurred in 4 patients and 11 grade IV gastrointestinal events that occurred in 8 patients. On univariate analysis of grade I–IV events a statistically significant association was observed with the following variables: histological grade, peritoneal cancer index (PCI), small bowel resection, colorectal anastomosis, and the number of anastomoses performed per patient. By multivariate analysis, PCI was identified as the only independent risk factor for gastrointestinal complications. CRS combined with a uniform HIPEC regimen is associated with a 17% gastrointestinal morbidity rate (grade I–IV). The frequency of gastrointestinal complications was associated with a large extent of disease measured by PCI (>30).

Autor:innen und Institutionen

  • Washington Cancer Institute, Washington Hospital Center, Washington, DC 20010, USA.

Zitieren

APA

Casado-Adam, A., Alderman, R., Stuart, O. A., Chang, D., & Sugarbaker, P. H. (2011). Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy. International Journal of Surgical Oncology. https://doi.org/10.1155/2011/468698

Vancouver

Casado-Adam A, Alderman R, Stuart OA, Chang D, Sugarbaker PH. Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy. International Journal of Surgical Oncology. 2011. doi:10.1155/2011/468698

BibTeX
@article{CasadoAdam2011,
  author = {Casado-Adam, Angela and Alderman, Robert and Stuart, O Anthony and Chang, David and Sugarbaker, Paul H},
  title = {Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy},
  journal = {International Journal of Surgical Oncology},
  year = {2011},
  doi = {10.1155/2011/468698}
}
Kostenlos starten →